HHS plans to let compounding pharmacies produce unapproved peptides
The Trump administration is moving forward with a plan to allow compounding pharmacies to manufacture specific peptides that lack FDA approval.
Regulatory shift for wellness injections
The Associated Press reports that the Department of Health and Human Services intends to authorize these productions. These substances are largely unregulated injections popular among followers of Secretary Robert F. Kennedy Jr.
Safety concerns remain high
Most available data on these peptides comes from animal studies rather than human trials. The Food and Drug Administration has not approved them as safe or effective for use.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.